What Is Lyophilization and Why Are Peptides Freeze-Dried?

What is lyophilization?

Lyophilization is the removal of water from a frozen solution by sublimation under reduced pressure, so that ice passes directly to vapour without returning to a liquid phase. Wang’s 2000 review in the International Journal of Pharmaceutics described it as the most commonly used method for preparing solid protein pharmaceuticals, and set out the reason plainly: the limited physical and chemical stability of these molecules means they often have to be made into solid forms to achieve an acceptable shelf life (source 1).

What arrives in a research vial is the residue of that process — the porous plug of solid, commonly called the cake, left standing in the space the ice occupied before it sublimed. Its appearance is a product of the drying conditions, and Tang and Pikal’s 2004 review of freeze-drying process design identifies loss of that structure as the defining consequence of running the product too warm during drying (source 2).

Why does water make a peptide unstable in the first place?

The case for drying a peptide is really a case against keeping it wet. Manning, Patel and Borchardt’s 1989 review in Pharmaceutical Research catalogued the decomposition routes available to these molecules and split them in two. Chemical instability covered proteolysis, deamidation, oxidation, racemization and beta-elimination; physical instability covered aggregation, precipitation, denaturation and adsorption to surfaces (source 5). The 2010 update by Manning and colleagues revisited the same framework two decades later and added dedicated sections on stabilization in aqueous solution and in the dried state, alongside the interrelationship between the chemical and physical routes (source 6).

A 2023 review in Pharmaceutics restated the underlying problem for peptides specifically: they are often unstable in aqueous solutions, which affects both stability and bioactivity, and that instability is what a dry formulation for later reconstitution is designed around (source 7).

Deamidation illustrates how measurable this is. Robinson and Robinson determined the deamidation rates of 306 asparaginyl sequences in model peptides at pH 7.4 and 37.0 °C in 0.15 M Tris·HCl buffer, and established a library of 913 amide-containing peptides for other investigators working on the same question (source 8). The rates they measured varied with sequence context, which is the observation behind the proposal that glutaminyl and asparaginyl residues act as molecular clocks. For a laboratory, the practical reading is that a peptide in buffer is running a reaction whose rate is set by its own sequence, its pH and its temperature — and that removing the solvent removes the reaction medium.

What are the three stages of a lyophilization cycle?

Tang and Pikal organised freeze-drying process design around three sequential stages, each governed by different parameters (source 2).

The division matters because the two drying stages remove different water. Primary drying takes out the ice, which is the bulk of it. Secondary drying takes out what is left behind clinging to the solid, and that remainder is what governs how the cake behaves in storage.

What is Tg′ and why does it limit primary drying?

Freezing does not produce pure ice and pure solid. It produces ice plus a freeze-concentrated phase containing the peptide, any excipients and the water that never crystallised. That freeze-concentrate has a thermal transition of its own, denoted Tg′, and Tang and Pikal discuss its significance alongside the collapse temperature when selecting the target product temperature for primary drying (source 2).

The constraint is straightforward in principle and demanding in practice. Sublimation is faster at higher product temperature, so there is a commercial incentive to run warm; exceed the collapse temperature and the matrix loses the structure that makes it a cake. Carpenter, Pikal, Chang and Randolph addressed the same tension in their 1997 Pharmaceutical Research paper on the rational design of stable lyophilized formulations, which set out practical advice rather than leaving the choice to trial and error (source 3) — an approach Tang and Pikal explicitly contrast with adopting whatever protocol the first laboratory run happened to use (source 2).

How much water is left after drying, and why does the leftover matter?

Residual moisture is the variable that connects a finished cake to its shelf life, and Breen and colleagues measured that relationship directly. Working with a humanized monoclonal antibody lyophilized in a sucrose, histidine and polysorbate 20 formulation, they prepared material at residual moistures from 1 to 8 percent and stored vials at temperatures from 5 to 50 °C for 6 or 12 months. The glass transition temperature of the solid fell from 80 °C at 1 percent moisture to 25 °C at 8 percent, with no cake collapse and no differences in secondary structure detected by Fourier transform infrared spectroscopy across the moisture range. All the formulations were stable at 5 °C (source 10).

That 55-degree swing is the point. Hancock and Zografi had already characterised water as a potent plasticizer of amorphous pharmaceutical solids, reporting a rapid initial reduction in glass transition temperature as water is absorbed from the dry state, which then levels off at higher water contents and can be described by a simplified form of the Gordon-Taylor/Kelley-Bueche relationship (source 9). A solid stored below its glass transition temperature is a rigid glass; the same solid carrying more water can have a glass transition low enough to sit near ambient conditions.

Drying also does not stop chemistry outright. Lai and Topp’s review of solid-state stability enumerated the reactions that still proceed in dried peptides and proteins — deamidation, peptide bond cleavage, oxidation, the Maillard reaction, beta-elimination and dimerization or aggregation — and identified temperature, moisture content, excipients and the physical state of the formulation, amorphous versus crystalline, as the factors that influence them (source 4). Freeze-drying slows the clock; it does not remove it, which is why storage temperature remains a specification on a research vial rather than a suggestion.

What do lyoprotectants do in a freeze-dried peptide formulation?

Many lyophilized formulations contain sugars or polyols that are not the active molecule. Carpenter and Crowe examined what those additives are doing using Fourier-transform infrared spectroscopy. Freeze-drying trehalose, lactose or myo-inositol together with lysozyme produced substantial alterations in the infrared spectra of the dried carbohydrates, with band shifts and loss of splitting in the fingerprint region that mimicked the effects of water on hydrated trehalose. In the complementary experiment, dehydration-induced shifts in the lysozyme amide I and amide II bands were partially and fully reversed respectively when the protein was freeze-dried in the presence of the carbohydrate (source 11).

That result is the observational core of the water-replacement account: the sugar hydrogen-bonds to the dried molecule roughly where water used to. Jain and Roy’s review of trehalose describes it as a stress-responsive molecule that organisms accumulate under heat, cold, oxidation and desiccation, protecting cellular proteins that would otherwise degrade under those conditions (source 12). Wang’s review organises the same subject as cryo- and lyo-protection of proteins by excipients, distinguishing protection during the freezing step from protection during drying (source 1).

Does the freeze-drying process itself stress the peptide?

It does, and the literature is direct about it. Wang notes that lyophilization generates both freezing and drying stresses capable of denaturing proteins to various degrees, and adds that even after a successful run with a stabilizer present, a protein in the solid state may still have limited long-term storage stability (source 1). Freeze-drying is therefore not a neutral packaging step. It is a manufacturing operation with its own failure modes, which is why Tang and Pikal argue for designing the process from accepted physical principles instead of inheriting a protocol (source 2).

What does this mean for a vial on the bench?

Three consequences follow for a laboratory handling lyophilized material. First, the dry state is the stable state, so a vial that will not be used immediately is better left sealed and dry than reconstituted early. Second, once solvent is added the peptide re-enters the aqueous regime that the 2023 Pharmaceutics review describes as the unstable one (source 7), which is why reconstituted solutions carry shorter handling windows than the powder did. Third, moisture ingress into a stored cake is not a cosmetic issue: it lowers the glass transition temperature of the solid, as Hancock and Zografi and Breen and colleagues both document (sources 9, 10), which is the mechanism behind sealing, desiccation and cold storage practice.

Steadfast Research Group ships research peptides in lyophilized form for exactly these reasons, with batch-matched analytical documentation reflecting the material as tested at release. The purity figure on that document describes the batch at its date of analysis; what happens to it afterwards is a function of how the cake is stored and when it is put into solution.